Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes

Aims  Acute insulin release (AIR) in response to intravenous glucose injection (IVGTT) can be abolished in diabetic subjects when their response to oral glucose is maintained. To elucidate this phenomenon, we examined the relationships between fasting plasma glucose (FPG) and the secretory responses to an IVGTT and an oral glucose test (OGTT).

[1]  A. Mari.  Methods of Assessment of Insulin Sensitivity and β-Cell Function , 2006 .

[2]  Giovanni Pacini,et al.  Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. , 1998, American journal of physiology. Endocrinology and metabolism.

[3]  Andrea Mari,et al.  Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients , 2008, Diabetes.

[4]  Masafumi Matsuda,et al.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[5]  Andrea Mari,et al.  Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. , 2002, American journal of physiology. Endocrinology and metabolism.

[6]  M. Noda,et al.  Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. , 1999, Diabetes.

[7]  Andrea Mari,et al.  Assessment of insulin secretion in relation to insulin resistance , 2005, Current opinion in clinical nutrition and metabolic care.

[8]  D. Porte,et al.  Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.

[9]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[10]  Andrea Tura,et al.  Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. , 2002, Diabetes.

[11]  M. Ravier,et al.  Signals and pools underlying biphasic insulin secretion. , 2002, Diabetes.

[12]  A. Mari,et al.  Beta cell function and its relation to insulin action in humans: a critical appraisal , 2004, Diabetologia.

[13]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[14]  Andrea Mari,et al.  A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test , 2001 .

[15]  E. Ferrannini,et al.  Effect of acute hyperglycemia on insulin secretion in humans. , 2002, Diabetes.

[16]  I. Godsland,et al.  Loss of beta cell function as fasting glucose increases in the non-diabetic range , 2004, Diabetologia.

[17]  M. T. Brennan,et al.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. , 1967, The Journal of clinical investigation.

[18]  J. Henquin,et al.  Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.

[19]  J. Weng,et al.  Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. , 2004, Diabetes care.